-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Absci (NASDAQ:ABSI) Shares Up 1%
Absci (NASDAQ:ABSI) Shares Up 1%
Shares of Absci Co. (NASDAQ:ABSI – Get Rating) traded up 1% during mid-day trading on Tuesday . The company traded as high as $3.25 and last traded at $3.12. 466,859 shares were traded during trading, a decline of 0% from the average session volume of 468,491 shares. The stock had previously closed at $3.09.
Absci Price Performance
The stock's 50-day moving average is $2.49 and its 200-day moving average is $3.12. The firm has a market cap of $304.90 million, a P/E ratio of -2.65 and a beta of 0.62. The company has a quick ratio of 6.71, a current ratio of 6.71 and a debt-to-equity ratio of 0.03.
Get Absci alerts:Absci (NASDAQ:ABSI – Get Rating) last issued its earnings results on Wednesday, November 9th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $2.37 million during the quarter, compared to analyst estimates of $1.79 million. Absci had a negative net margin of 1,960.28% and a negative return on equity of 33.62%. As a group, equities analysts anticipate that Absci Co. will post -1.13 EPS for the current fiscal year.
Hedge Funds Weigh In On Absci
Several institutional investors and hedge funds have recently modified their holdings of ABSI. D Orazio & Associates Inc. bought a new stake in Absci in the 4th quarter valued at $32,000. Metropolitan Life Insurance Co NY acquired a new stake in Absci in the first quarter valued at about $33,000. Two Sigma Advisers LP acquired a new stake in Absci in the third quarter valued at about $34,000. Ameritas Investment Partners Inc. boosted its stake in Absci by 305.3% in the first quarter. Ameritas Investment Partners Inc. now owns 4,312 shares of the company's stock valued at $36,000 after buying an additional 3,248 shares in the last quarter. Finally, ProShare Advisors LLC acquired a new stake in Absci in the third quarter valued at about $42,000. 47.59% of the stock is currently owned by institutional investors and hedge funds.Absci Company Profile
(Get Rating)
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.
Read More
- Get a free copy of the StockNews.com research report on Absci (ABSI)
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of Absci Co. (NASDAQ:ABSI – Get Rating) traded up 1% during mid-day trading on Tuesday . The company traded as high as $3.25 and last traded at $3.12. 466,859 shares were traded during trading, a decline of 0% from the average session volume of 468,491 shares. The stock had previously closed at $3.09.
Absci Co.的股票纳斯达克股票代码：ABSI — Get Rating）在周二午盘交易中上涨了1％。该公司的交易价格高达3.25美元，最后一次交易价格为3.12美元。交易期间交易了466,859股，较平均交易日交易量468,491股下降了0％。该股此前收于3.09美元。
Absci Price Performance
Absci 价格表现
The stock's 50-day moving average is $2.49 and its 200-day moving average is $3.12. The firm has a market cap of $304.90 million, a P/E ratio of -2.65 and a beta of 0.62. The company has a quick ratio of 6.71, a current ratio of 6.71 and a debt-to-equity ratio of 0.03.
该股的50天移动平均线为2.49美元，其200天移动平均线为3.12美元。该公司的市值为3.049亿美元，市盈率为-2.65，beta值为0.62。该公司的速动比率为6.71，流动比率为6.71，债务与权益比率为0.03。
Absci (NASDAQ:ABSI – Get Rating) last issued its earnings results on Wednesday, November 9th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $2.37 million during the quarter, compared to analyst estimates of $1.79 million. Absci had a negative net margin of 1,960.28% and a negative return on equity of 33.62%. As a group, equities analysts anticipate that Absci Co. will post -1.13 EPS for the current fiscal year.
Absci（纳斯达克股票代码：ABSI — Get Rating）最后一次发布财报是在11月9日星期三。该公司公布了本季度每股收益（0.30美元），比市场普遍预期的（0.27美元）低了（0.03美元）。该公司在本季度的收入为237万美元，而分析师的估计为179万美元。Absci的净利润率为负1,960.28％，负股本回报率为33.62％。作为一个整体，股票分析师预计，Absci Co. 将在本财年公布每股收益为-1.13。
Hedge Funds Weigh In On Absci
对冲基金权衡Absci
Absci Company Profile
Absci 公司简介
(Get Rating)
（获取评分）
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.
Absci Corporation是一家药物和靶点发现公司，它使用综合药物创制平台为美国的合作伙伴提供生物候选药物和生产细胞系。其集成的药物创制平台通过将药物发现和细胞系开发过程统一为一个过程，实现了生物制剂的创造。
Read More
阅读更多
- Get a free copy of the StockNews.com research report on Absci (ABSI)
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
- 免费获取 StockNews.com 关于 Absci（ABSI）的研究报告的副本
- 雪佛龙通过750亿美元的股票回购使股东感到高兴
- 电子商务的未来：分析和新数据
- 李维·施特劳斯非常适合收入投资者
- 3 个有很大上升空间的小盘股
- Mullen Automotive：好消息、坏消息和丑陋前景
Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Absci Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Absci及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧